Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 05, 2019

SELL
$8.38 - $13.44 $127,845 - $205,040
-15,256 Closed
0 $0
Q3 2018

Nov 02, 2018

BUY
$11.6 - $16.54 $4,860 - $6,930
419 Added 2.82%
15,256 $0
Q2 2018

Aug 20, 2018

SELL
$13.13 - $17.09 $139,335 - $181,359
-10,612 Reduced 41.7%
14,837 $0
Q1 2018

May 21, 2018

BUY
$13.76 - $17.12 $350,178 - $435,686
25,449 New
25,449 $0

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.44B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.